Publicaciones en las que colabora con Jonay García Luis (11)

2022

  1. Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19

    Frontiers in Bioengineering and Biotechnology, Vol. 10

  2. Transactive Response DNA-Binding Protein (TARDBP/TDP-43) Regulates Cell Permissivity to HIV-1 Infection by Acting on HDAC6

    International Journal of Molecular Sciences, Vol. 23, Núm. 11

2018

  1. Fanconi anaemia-like mph1 helicase backs up rad54 and rad5 to circumvent replication stress-driven chromosome bridges

    Genes, Vol. 9, Núm. 11

  2. Lawsone, Juglone, and β-Lapachone Derivatives with Enhanced Mitochondrial-Based Toxicity

    ACS Chemical Biology, Vol. 13, Núm. 8, pp. 1950-1957

2016

  1. Cdc14 phosphatase: warning, no delay allowed for chromosome segregation!

    Current Genetics, Vol. 62, Núm. 1, pp. 7-13

2014

  1. Cdc14 targets the holliday junction resolvase Yen1 to the nucleus in early anaphase

    Cell Cycle, Vol. 13, Núm. 9, pp. 1392-1399

  2. Mus81-mms4 and yen1 resolve a novel anaphase bridge formed by noncanonical holliday junctions

    Nature Communications, Vol. 5

  3. Yeast cytotoxic sensitivity to the antitumour agent β-lapachone depends mainly on oxidative stress and is largely independent of microtubule- or topoisomerase-mediated DNA damage

    Biochemical Pharmacology, Vol. 92, Núm. 2, pp. 206-219

2013

  1. Synthesis and study of antiproliferative, antitopoisomerase II, DNA-intercalating and DNA-damaging activities of arylnaphthalimides

    Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 21, pp. 6484-6495

2012

  1. Nondisjunction of a single chromosome leads to breakage and activation of DNA damage checkpoint in G2

    PLoS Genetics, Vol. 8, Núm. 2

2011

  1. No role of homologous recombination in dealing with β-lapachone cytotoxicity in yeast

    Chemical Research in Toxicology, Vol. 24, Núm. 12, pp. 2106-2108